(Q41899388)

13 October 2017

Low-dose aspirin as treatment for central serous chorioretinopathy (English)

1 reference

13 October 2017

1 reference

Antonio Caccavale

1

1 reference

13 October 2017

Filippo Romanazzi

2

1 reference

13 October 2017

Manuela Imparato

3

1 reference

13 October 2017

Angelo Negri

4

1 reference

13 October 2017

Anna Morano

5

1 reference

13 October 2017

Fabio Ferentini

6

1 reference

13 October 2017

language of work or name

English

0 references

publication date

9 August 2010

1 reference

13 October 2017

Clinical Ophthalmology

1 reference

13 October 2017

4

1 reference

13 October 2017

899-903

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

13 October 2017

start time

1 August 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The effect of intravitreal bevacizumab in patients with acute central serous chorioretinopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Ketoconazole in the treatment of central serous chorioretinopathy: a pilot study

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

A new strategy of treatment with low-dosage acetyl salicylic acid in patients affected by central serous chorioretinopathy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Ocular disease in pregnancy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Digestive and hemorrhage complications of low-dose aspirin

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Retinal complications of bone marrow and solid organ transplantation

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Features of abnormal choroidal circulation in central serous chorioretinopathy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Central serous chorioretinopathy and glucocorticoids

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Long-term follow-up of idiopathic central serous chorioretinopathy without laser

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

[Central serous chorioretinopathy and systemic steroid therapy].

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Idiopathic central serous chorioretinopathy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Endogenous cortisol profile in patients with central serous chorioretinopathy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Central serous chorioretinopathy in patients with systemic lupus erythematosus

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Choroidal capillary and venous congestion in central serous chorioretinopathy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Central serous chorioretinopathy in endogenous hypercortisolism.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Central serous chorioretinopathy and indocyanine green angiography.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Long-term follow-up of central serous chorioretinopathy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Ulcerative colitis complicated by idiopathic central serous chorioretinopathy with bullous retinal detachment.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Eight-year follow-up of central serous chorioretinopathy with and without laser treatment

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Type-A behavior and central serous chorioretinopathy.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Ibuprofen in the treatment of central serous chorioretinopathy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Systemic findings associated with central serous chorioretinopathy.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Intravitreal bevacizumab in treatment of idiopathic persistent central serous chorioretinopathy: a prospective, controlled clinical study

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Ocular disorders in renal transplant patients

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Ketoconazole in the treatment of chronic idiopathic central serous chorioretinopathy.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Alterations of retinal pigment epithelium in central serous chorioretinopathy.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Central serous chorioretinopathy in giant cell arteritis.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Risk factors for central serous chorioretinopathy: a case-control study

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Endocrine abnormalities in patients with central serous chorioretinopathy

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Central serous chorioretinopathy

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921298

Sympathetic-parasympathetic activity and reactivity in central serous chorioretinopathy: a case-control study

30 September 2018

1 reference

12 December 2020

[Study of choroidal vascular lesions in central serous chorioretinopathy using indocyanine green angiography]

1 reference

12 December 2020

Plasminogen activator inhibitor 1 in central serous chorioretinopathy

1 reference

12 December 2020

Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy

1 reference

12 December 2020

[Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-1 in blood obtained from patients of idiopathic central serous chorioretinopathy]

1 reference

12 December 2020

Crohn's disease complicated by idiopathic central serous chorioretinopathy with bullous retinal detachment

1 reference

12 December 2020

Identifiers

DOI

10.2147/OPTH.S12583

1 reference

13 October 2017

1 reference

13 October 2017

PubMed publication ID

20714368

1 reference